{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T22:43:35Z","timestamp":1778885015646,"version":"3.51.4"},"reference-count":87,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2017,4,1]],"date-time":"2017-04-01T00:00:00Z","timestamp":1491004800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,4,1]],"date-time":"2017-04-01T00:00:00Z","timestamp":1491004800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,9,12]],"date-time":"2020-09-12T00:00:00Z","timestamp":1599868800000},"content-version":"vor","delay-in-days":1260,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000001","name":"National Science Foundation","doi-asserted-by":"publisher","award":["DGE-1144081"],"award-info":[{"award-number":["DGE-1144081"]}],"id":[{"id":"10.13039\/100000001","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006955","name":"Office of Extramural Research, National Institutes of Health","doi-asserted-by":"publisher","award":["R01AI103311"],"award-info":[{"award-number":["R01AI103311"]}],"id":[{"id":"10.13039\/100006955","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006955","name":"Office of Extramural Research, National Institutes of Health","doi-asserted-by":"publisher","award":["R21AI123811"],"award-info":[{"award-number":["R21AI123811"]}],"id":[{"id":"10.13039\/100006955","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006955","name":"Office of Extramural Research, National Institutes of Health","doi-asserted-by":"publisher","award":["T32 AI07419"],"award-info":[{"award-number":["T32 AI07419"]}],"id":[{"id":"10.13039\/100006955","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006955","name":"Office of Extramural Research, National Institutes of Health","doi-asserted-by":"publisher","award":["P30 CA016086"],"award-info":[{"award-number":["P30 CA016086"]}],"id":[{"id":"10.13039\/100006955","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["mcponline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular & Cellular Proteomics"],"published-print":{"date-parts":[[2017,4]]},"DOI":"10.1074\/mcp.m116.065375","type":"journal-article","created":{"date-parts":[[2017,2,25]],"date-time":"2017-02-25T20:10:20Z","timestamp":1488053420000},"page":"S263-S276","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":30,"special_numbering":"S1","title":["Kinome Profiling Identifies Druggable Targets for Novel Human Cytomegalovirus (HCMV) Antivirals"],"prefix":"10.1016","volume":"16","author":[{"given":"Kyle C.","family":"Arend","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erik M.","family":"Lenarcic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heather A.","family":"Vincent","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naim","family":"Rashid","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eric","family":"Lazear","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ian M.","family":"McDonald","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas S.K.","family":"Gilbert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael P.","family":"East","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura E.","family":"Herring","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gary L.","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lee M.","family":"Graves","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nathaniel J.","family":"Moorman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1074\/mcp.M116.065375_bib1","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.jhealeco.2016.01.012","article-title":"Innovation in the pharmaceutical industry: New estimates of R&D costs","volume":"47","author":"DiMasi","year":"2016","journal-title":"J. Health Econ"},{"key":"10.1074\/mcp.M116.065375_bib2","doi-asserted-by":"crossref","first-page":"731","DOI":"10.2217\/fmb.09.40","article-title":"Molecular targets for antiviral therapy of cytomegalovirus infections","volume":"4","author":"Marschall","year":"2009","journal-title":"Future Microbiol"},{"key":"10.1074\/mcp.M116.065375_bib3","doi-asserted-by":"crossref","first-page":"S32","DOI":"10.1086\/320902","article-title":"Management of cytomegalovirus infection and disease after solid-organ transplantation","volume":"33","author":"van der Bij","year":"2001","journal-title":"Clin. Infect. Dis"},{"key":"10.1074\/mcp.M116.065375_bib4","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1002\/path.4437","article-title":"The pathogenesis of human cytomegalovirus","volume":"235","author":"Griffiths","year":"2015","journal-title":"J. Pathol"},{"key":"10.1074\/mcp.M116.065375_bib5","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.2146\/ajhp090424","article-title":"Drug interactions and toxicities associated with the antiviral management of cytomegalovirus infection","volume":"67","author":"Jacobsen","year":"2010","journal-title":"Am. J. Health Syst. Pharm"},{"key":"10.1074\/mcp.M116.065375_bib6","doi-asserted-by":"crossref","first-page":"965","DOI":"10.2165\/10898540-000000000-00000","article-title":"New developments in the management of cytomegalovirus infection after solid organ transplantation","volume":"70","author":"Eid","year":"2010","journal-title":"Drugs"},{"key":"10.1074\/mcp.M116.065375_bib7","doi-asserted-by":"crossref","first-page":"e132","DOI":"10.1371\/journal.ppat.0020132","article-title":"Dynamics of the cellular metabolome during human cytomegalovirus infection","volume":"2","author":"Munger","year":"2006","journal-title":"PLoS Pathog"},{"key":"10.1074\/mcp.M116.065375_bib8","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1038\/nbt.1500","article-title":"Systems-level metabolic flux profiling identifies fatty acid synthesis as a target for antiviral therapy","volume":"26","author":"Munger","year":"2008","journal-title":"Nat. Biotechnol"},{"key":"10.1074\/mcp.M116.065375_bib9","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1146\/annurev-virology-031413-085425","article-title":"Human Cytomegalovirus: Coordinating Cellular Stress, Signaling, and Metabolic Pathways","volume":"1","author":"Shenk","year":"2014","journal-title":"Annu. Rev. Virol"},{"key":"10.1074\/mcp.M116.065375_bib10","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1002\/rmv.551","article-title":"The S phase of the cell cycle and its perturbation by human cytomegalovirus","volume":"17","author":"Bain","year":"2007","journal-title":"Rev. Med. Virol"},{"key":"10.1074\/mcp.M116.065375_bib11","first-page":"243","article-title":"Subversion of cell cycle regulatory pathways","volume":"325","author":"Sanchez","year":"2008","journal-title":"Curr. Top. Microbiol. Immunol"},{"key":"10.1074\/mcp.M116.065375_bib12","first-page":"205","article-title":"Human cytomegalovirus modulation of signal transduction","volume":"325","author":"Yurochko","year":"2008","journal-title":"Curr. Top. Microbiol. Immunol"},{"key":"10.1074\/mcp.M116.065375_bib13","doi-asserted-by":"crossref","first-page":"97","DOI":"10.3390\/v8040097","article-title":"Human cytomegalovirus strategies to maintain and promote mRNA translation","volume":"8","author":"Vincent","year":"2016","journal-title":"Viruses"},{"key":"10.1074\/mcp.M116.065375_bib14","doi-asserted-by":"crossref","first-page":"ea012351","DOI":"10.1101\/cshperspect.a012351","article-title":"Tinkering with translation: protein synthesis in virus-infected cells","volume":"5","author":"Walsh","year":"2013","journal-title":"Cold Spring Harb. Perspect. Biol"},{"key":"10.1074\/mcp.M116.065375_bib15","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.antiviral.2016.12.006","article-title":"Identification of compounds with anti-human cytomegalovirus activity that inhibit production of IE2 proteins","volume":"138","author":"Beelontally","year":"2017","journal-title":"Antiviral Res"},{"key":"10.1074\/mcp.M116.065375_bib16","doi-asserted-by":"crossref","DOI":"10.1099\/jgv.0.000713","article-title":"High throughput screening of a GlaxoSmithKline protein kinase inhibitor set identifies an inhibitor of human cytomegalovirus replication that prevents CREB and histone H3 post-translational modification","author":"Khan","year":"2017","journal-title":"J. Gen. Virol"},{"key":"10.1074\/mcp.M116.065375_bib17","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.chembiol.2015.12.012","article-title":"Drug repurposing approach identifies inhibitors of the prototypic viral transcription factor IE2 that block human cytomegalovirus replication","volume":"23","author":"Mercorelli","year":"2016","journal-title":"Cell Chem. Biol"},{"key":"10.1074\/mcp.M116.065375_bib18","doi-asserted-by":"crossref","first-page":"3839","DOI":"10.1128\/JVI.02714-15","article-title":"Human cytomegalovirus pTRS1 and pIRS1 antagonize protein kinase R to facilitate virus replication","volume":"90","author":"Ziehr","year":"2016","journal-title":"J. Virol"},{"key":"10.1074\/mcp.M116.065375_bib19","doi-asserted-by":"crossref","first-page":"6022","DOI":"10.1128\/JVI.75.13.6022-6032.2001","article-title":"Human cytomegalovirus up-regulates the phosphatidylinositol 3-kinase (PI3-K) pathway: inhibition of PI3-K activity inhibits viral replication and virus-induced signaling","volume":"75","author":"Johnson","year":"2001","journal-title":"J. Virol"},{"key":"10.1074\/mcp.M116.065375_bib20","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.chom.2008.03.002","article-title":"Human cytomegalovirus protein UL38 inhibits host cell stress responses by antagonizing the tuberous sclerosis protein complex","volume":"3","author":"Moorman","year":"2008","journal-title":"Cell Host Microbe"},{"key":"10.1074\/mcp.M116.065375_bib21","doi-asserted-by":"crossref","first-page":"e1002502","DOI":"10.1371\/journal.ppat.1002502","article-title":"HCMV targets the metabolic stress response through activation of AMPK whose activity is important for viral replication","volume":"8","author":"McArdle","year":"2012","journal-title":"PLoS Pathog"},{"key":"10.1074\/mcp.M116.065375_bib22","doi-asserted-by":"crossref","first-page":"3071","DOI":"10.1073\/pnas.1200494109","article-title":"Human kinome profiling identifies a requirement for AMP-activated protein kinase during human cytomegalovirus infection","volume":"109","author":"Terry","year":"2012","journal-title":"Proc. Natl. Acad. Sci. U.S.A"},{"key":"10.1074\/mcp.M116.065375_bib23","doi-asserted-by":"crossref","first-page":"5260","DOI":"10.1128\/JVI.02733-09","article-title":"Rapamycin-resistant mTORC1 kinase activity is required for herpesvirus replication","volume":"84","author":"Moorman","year":"2010","journal-title":"J. Virol"},{"key":"10.1074\/mcp.M116.065375_bib24","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1089\/adt.2015.0003.drrr","article-title":"Repurposing kinase inhibitors as antiviral agents to control influenza a virus replication assay","volume":"13","author":"Perwitasari","year":"2015","journal-title":"Drug Dev. Technol"},{"key":"10.1074\/mcp.M116.065375_bib25","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.antiviral.2015.05.003","article-title":"Inhibitors of cellular kinases with broad-spectrum antiviral activity for hemorrhagic fever viruses","volume":"120","author":"Mohr","year":"2015","journal-title":"Antiviral Res"},{"key":"10.1074\/mcp.M116.065375_bib26","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1182\/blood-2007-01-069294","article-title":"Sirolimus-based graft-versus-host disease prophylaxis protects against cytomegalovirus reactivation after allogeneic hematopoietic stem cell transplantation: a cohort analysis","volume":"110","author":"Marty","year":"2007","journal-title":"Blood"},{"key":"10.1074\/mcp.M116.065375_bib27","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.cell.2012.02.053","article-title":"Dynamic reprogramming of the kinome in response to targeted MEK inhibition in triple-negative breast cancer","volume":"149","author":"Duncan","year":"2012","journal-title":"Cell"},{"key":"10.1074\/mcp.M116.065375_bib28","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.1074\/mcp.M800588-MCP200","article-title":"Large-scale proteomics analysis of the human kinome","volume":"8","author":"Oppermann","year":"2009","journal-title":"Mol. Cell. Proteomics"},{"key":"10.1074\/mcp.M116.065375_bib29","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1021\/cb5008794","article-title":"Quantitative proteomics of kinase inhibitor targets and mechanisms","volume":"10","author":"Daub","year":"2015","journal-title":"ACS Chem. Biol"},{"key":"10.1074\/mcp.M116.065375_bib30","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1042\/BJ20121456","article-title":"The dynamic nature of the kinome","volume":"450","author":"Graves","year":"2013","journal-title":"Biochem. J"},{"key":"10.1074\/mcp.M116.065375_bib31","doi-asserted-by":"crossref","first-page":"2743","DOI":"10.1021\/acschembio.5b00616","article-title":"Evaluation of Kinase Activity Profiling Using Chemical Proteomics","volume":"10","author":"Ruprecht","year":"2015","journal-title":"ACS Chem. Biol"},{"key":"10.1074\/mcp.M116.065375_bib32","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1038\/nbt1328","article-title":"Quantitative chemical proteomics reveals mechanisms of action of clinical ABL kinase inhibitors","volume":"25","author":"Bantscheff","year":"2007","journal-title":"Nat. Biotechnol"},{"key":"10.1074\/mcp.M116.065375_bib33","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1074\/mcp.T600062-MCP200","article-title":"Proteomics analysis of protein kinases by target class-selective prefractionation and tandem mass spectrometry","volume":"6","author":"Wissing","year":"2007","journal-title":"Mol. Cell. Proteomics"},{"key":"10.1074\/mcp.M116.065375_bib34","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1042\/BST20130274","article-title":"Assessing adaptation of the cancer kinome in response to targeted therapies","volume":"42","author":"Zawistowski","year":"2014","journal-title":"Biochem. Soc. Trans"},{"key":"10.1074\/mcp.M116.065375_bib35","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/j.celrep.2015.03.037","article-title":"Inhibition of lapatinib-induced kinome reprogramming in ERBB2-positive breast cancer by targeting BET family bromodomains","volume":"11","author":"Stuhlmiller","year":"2015","journal-title":"Cell Rep"},{"key":"10.1074\/mcp.M116.065375_bib36","doi-asserted-by":"crossref","first-page":"2516","DOI":"10.1158\/1078-0432.CCR-13-1081","article-title":"Molecular pathways: adaptive kinome reprogramming in response to targeted inhibition of the BRAF-MEK-ERK pathway in cancer","volume":"20","author":"Johnson","year":"2014","journal-title":"Clin. Cancer Res"},{"key":"10.1074\/mcp.M116.065375_bib37","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/j.chembiol.2011.06.001","article-title":"\u201cGoing KiNativ\u201d: probing the native kinome","volume":"18","author":"Graves","year":"2011","journal-title":"Chem. Biol"},{"key":"10.1074\/mcp.M116.065375_bib38","doi-asserted-by":"crossref","first-page":"9773","DOI":"10.1021\/acs.analchem.6b02816","article-title":"A high-throughput targeted proteomic approach for comprehensive profiling of methylglyoxal-induced perturbations of the human kinome","volume":"88","author":"Miao","year":"2016","journal-title":"Anal. Chem"},{"key":"10.1074\/mcp.M116.065375_bib39","doi-asserted-by":"crossref","first-page":"e66755","DOI":"10.1371\/journal.pone.0066755","article-title":"Application of multiplexed kinase inhibitor beads to study kinome adaptations in drug-resistant leukemia","volume":"8","author":"Cooper","year":"2013","journal-title":"PLoS ONE"},{"key":"10.1074\/mcp.M116.065375_bib40","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1016\/j.celrep.2016.06.091","article-title":"Resistance to BET bromodomain inhibitors is mediated by kinome reprogramming in ovarian cancer","volume":"16","author":"Kurimchak","year":"2016","journal-title":"Cell Rep"},{"key":"10.1074\/mcp.M116.065375_bib41","article-title":"Probing the global kinome and phosphoproteome in Chlamydomonas reinhardtii via sequential enrichment and quantitative proteomics","author":"Werth","year":"2016","journal-title":"Plant J"},{"key":"10.1074\/mcp.M116.065375_bib42","doi-asserted-by":"crossref","first-page":"e84","DOI":"10.1038\/emi.2014.88","article-title":"Identification of 53 compounds that block Ebola virus-like particle entry via a repurposing screen of approved drugs","volume":"3","author":"Kouznetsova","year":"2014","journal-title":"Emerg. Microbes Infect"},{"key":"10.1074\/mcp.M116.065375_bib43","doi-asserted-by":"crossref","first-page":"e290ra289","DOI":"10.1126\/scitranslmed.aaa5597","article-title":"A screen of approved drugs and molecular probes identifies therapeutics with anti-Ebola virus activity","volume":"7","author":"Johansen","year":"2015","journal-title":"Sci. Transl. Med"},{"key":"10.1074\/mcp.M116.065375_bib44","doi-asserted-by":"crossref","first-page":"16642","DOI":"10.1073\/pnas.0407233101","article-title":"Human cytomegalovirus encodes a highly specific RANTES decoy receptor","volume":"101","author":"Wang","year":"2004","journal-title":"Proc. Natl. Acad. Sci. U.S.A"},{"key":"10.1074\/mcp.M116.065375_bib45","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1074\/mcp.M900485-MCP200","article-title":"A targeted spatial-temporal proteomics approach implicates multiple cellular trafficking pathways in human cytomegalovirus virion maturation","volume":"9","author":"Moorman","year":"2010","journal-title":"Mol. Cell. Proteomics"},{"key":"10.1074\/mcp.M116.065375_bib46","doi-asserted-by":"crossref","first-page":"8855","DOI":"10.1128\/JVI.00741-16","article-title":"Multiple transcripts encode full-length human cytomegalovirus IE1 and IE2 proteins during lytic infection","volume":"90","author":"Arend","year":"2016","journal-title":"J. Virol"},{"key":"10.1074\/mcp.M116.065375_bib47","series-title":"Generalized linear mixed models","author":"Charles","year":"2008"},{"key":"10.1074\/mcp.M116.065375_bib48","unstructured":"Bates, D., et al, (2014) lme4: Linear mixed-effects models using Eigen and S4, R package version 1.7,"},{"key":"10.1074\/mcp.M116.065375_bib49","doi-asserted-by":"crossref","first-page":"eS6","DOI":"10.1186\/1471-2105-13-S16-S6","article-title":"Statistical protein quantification and significance analysis in label-free LC-MS experiments with complex designs","volume":"13","author":"Clough","year":"2012","journal-title":"BMC Bioinformatics"},{"key":"10.1074\/mcp.M116.065375_bib50","article-title":"Package 'lmerTest\u2019","author":"Kuznetsova","year":"2015","journal-title":"R package version"},{"key":"10.1074\/mcp.M116.065375_bib51","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.2517-6161.1995.tb02031.x","article-title":"Controlling the false discovery rate: a practical and powerful approach to multiple testing","author":"Benjamini","year":"1995","journal-title":"J. Roy. Statistical Soc"},{"key":"10.1074\/mcp.M116.065375_bib52","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.virol.2015.02.008","article-title":"An unbiased proteomics approach to identify human cytomegalovirus RNA-associated proteins","volume":"481","author":"Lenarcic","year":"2015","journal-title":"Virology"},{"key":"10.1074\/mcp.M116.065375_bib53","doi-asserted-by":"crossref","first-page":"7960","DOI":"10.1128\/jvi.69.12.7960-7970.1995","article-title":"Human cytomegalovirus IE1 and IE2 proteins block apoptosis","volume":"69","author":"Zhu","year":"1995","journal-title":"J. Virol"},{"key":"10.1074\/mcp.M116.065375_bib54","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1128\/jvi.71.2.1485-1496.1997","article-title":"Characterization of the human cytomegalovirus irs1 and trs1 genes: a second immediate-early transcription unit within irs1 whose product antagonizes transcriptional activation","volume":"71","author":"Romanowski","year":"1997","journal-title":"J. Virol"},{"key":"10.1074\/mcp.M116.065375_bib55","doi-asserted-by":"crossref","first-page":"10594","DOI":"10.1128\/JVI.77.19.10594-10605.2003","article-title":"Human cytomegalovirus UL99-encoded pp28 is required for the cytoplasmic envelopment of tegument-associated capsids","volume":"77","author":"Silva","year":"2003","journal-title":"J. Virol"},{"key":"10.1074\/mcp.M116.065375_bib56","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.virol.2015.12.009","article-title":"The eIF4AIII RNA helicase is a critical determinant of human cytomegalovirus replication","volume":"489","author":"Ziehr","year":"2016","journal-title":"Virology"},{"key":"10.1074\/mcp.M116.065375_bib57","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1128\/JVI.02321-13","article-title":"Differential role for host translation factors in host and viral protein synthesis during human cytomegalovirus infection","volume":"88","author":"Lenarcic","year":"2014","journal-title":"J. Virol"},{"key":"10.1074\/mcp.M116.065375_bib58","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1099\/vir.0.83286-0","article-title":"Cloning and sequencing of a highly productive, endotheliotropic virus strain derived from human cytomegalovirus TB40\/E","volume":"89","author":"Sinzger","year":"2008","journal-title":"J. Gen. Virol"},{"key":"10.1074\/mcp.M116.065375_bib59","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1038\/nrm.2015.16","article-title":"Mechanisms of ephrin-Eph signalling in development, physiology and disease","volume":"17","author":"Kania","year":"2016","journal-title":"Nat. Rev. Mol. Cell Biol"},{"key":"10.1074\/mcp.M116.065375_bib60","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1038\/nrm3434","article-title":"TGFbeta signalling in context","volume":"13","author":"Massague","year":"2012","journal-title":"Nat. Rev. Mol. Cell Biol"},{"key":"10.1074\/mcp.M116.065375_bib61","doi-asserted-by":"crossref","first-page":"24200","DOI":"10.1074\/jbc.M113.471433","article-title":"Maternal embryonic leucine zipper kinase (MELK) reduces replication stress in glioblastoma cells","volume":"288","author":"Kig","year":"2013","journal-title":"J. Biol. Chem"},{"key":"10.1074\/mcp.M116.065375_bib62","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1158\/1535-7163.MCT-13-0764","article-title":"Maternal embryonic leucine zipper kinase: key kinase for stem cell phenotype in glioma and other cancers","volume":"13","author":"Ganguly","year":"2014","journal-title":"Mol. Cancer Therap"},{"key":"10.1074\/mcp.M116.065375_bib63","doi-asserted-by":"crossref","first-page":"40003","DOI":"10.1074\/jbc.M507274200","article-title":"Substrate specificity and activity regulation of protein kinase MELK","volume":"280","author":"Beullens","year":"2005","journal-title":"J. Biol. Chem"},{"key":"10.1074\/mcp.M116.065375_bib64","doi-asserted-by":"crossref","first-page":"9810","DOI":"10.1073\/pnas.1606862113","article-title":"Mitotic MELK-eIF4B signaling controls protein synthesis and tumor cell survival","volume":"113","author":"Yang","year":"2016","journal-title":"Proc. Natl. Acad. Sci. U.S.A"},{"key":"10.1074\/mcp.M116.065375_bib65","doi-asserted-by":"crossref","first-page":"e01763","DOI":"10.7554\/eLife.01763","article-title":"MELK is an oncogenic kinase essential for mitotic progression in basal-like breast cancer cells","volume":"3","author":"Wang","year":"2014","journal-title":"eLife"},{"key":"10.1074\/mcp.M116.065375_bib66","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.1128\/jvi.16.6.1560-1565.1975","article-title":"Human cytomegalovirus. IV. Specific inhibition of virus-induced DNA polymerase activity and viral DNA replication by phosphonoacetic acid","volume":"16","author":"Huang","year":"1975","journal-title":"J. Virol"},{"key":"10.1074\/mcp.M116.065375_bib67","doi-asserted-by":"crossref","first-page":"SA237","DOI":"10.1093\/infdis\/133.Supplement_2.A237","article-title":"Effective antiviral chemotherapy in cytomegalovirus infection of mice","volume":"133","author":"Overall","year":"1976","journal-title":"J. Infect. Dis"},{"key":"10.1074\/mcp.M116.065375_bib68","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1021\/cb500072z","article-title":"Acetyl-lysine binding site of bromodomain-containing protein 4 (BRD4) interacts with diverse kinase inhibitors","volume":"9","author":"Ember","year":"2014","journal-title":"ACS Chem. Biol"},{"key":"10.1074\/mcp.M116.065375_bib69","doi-asserted-by":"crossref","first-page":"17698","DOI":"10.18632\/oncotarget.4131","article-title":"BET inhibitor OTX015 targets BRD2 and BRD4 and decreases c-MYC in acute leukemia cells","volume":"6","author":"Coude","year":"2015","journal-title":"Oncotarget"},{"key":"10.1074\/mcp.M116.065375_bib70","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1158\/1541-7786.MCR-15-0472","article-title":"BET bromodomain inhibitors enhance efficacy and disrupt resistance to AR antagonists in the treatment of prostate cancer","volume":"14","author":"Asangani","year":"2016","journal-title":"Mol. Cancer Res"},{"key":"10.1074\/mcp.M116.065375_bib71","doi-asserted-by":"crossref","first-page":"1628","DOI":"10.1158\/1078-0432.CCR-14-1561","article-title":"The BET Bromodomain Inhibitor OTX015 Affects pathogenetic pathways in preclinical B-cell tumor models and synergizes with targeted drugs","volume":"21","author":"Boi","year":"2015","journal-title":"Clin. Cancer Res"},{"key":"10.1074\/mcp.M116.065375_bib72","doi-asserted-by":"crossref","first-page":"2155","DOI":"10.3390\/v6052155","article-title":"The DNA damage response induced by infection with human cytomegalovirus and other viruses","volume":"6","author":"Xiaofei","year":"2014","journal-title":"Viruses"},{"key":"10.1074\/mcp.M116.065375_bib73","doi-asserted-by":"crossref","first-page":"2273","DOI":"10.1158\/1535-7163.MCT-16-0300","article-title":"Spectrum and degree of CDK drug interactions predicts clinical performance","volume":"15","author":"Chen","year":"2016","journal-title":"Mol. Cancer Therap"},{"key":"10.1074\/mcp.M116.065375_bib74","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.18632\/oncotarget.790","article-title":"Development of an orally-administrative MELK-targeting inhibitor that suppresses the growth of various types of human cancer","volume":"3","author":"Chung","year":"2012","journal-title":"Oncotarget"},{"key":"10.1074\/mcp.M116.065375_bib75","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1128\/AAC.24.4.518","article-title":"Effect of 9-(1,3-dihydroxy-2-propoxymethyl)guanine on human cytomegalovirus replication in vitro","volume":"24","author":"Mar","year":"1983","journal-title":"Antimicrob. Agents Chemother"},{"key":"10.1074\/mcp.M116.065375_bib76","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1126\/science.1227919","article-title":"Decoding human cytomegalovirus","volume":"338","author":"Stern-Ginossar","year":"2012","journal-title":"Science"},{"key":"10.1074\/mcp.M116.065375_bib77","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1016\/j.cell.2014.04.028","article-title":"Quantitative temporal viromics: an approach to investigate host-pathogen interaction","volume":"157","author":"Weekes","year":"2014","journal-title":"Cell"},{"key":"10.1074\/mcp.M116.065375_bib78","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1099\/0022-1317-82-3-493","article-title":"The role of MKK1\/2 kinase activity in human cytomegalovirus infection","volume":"82","author":"Johnson","year":"2001","journal-title":"J. Gen. Virol"},{"key":"10.1074\/mcp.M116.065375_bib79","doi-asserted-by":"crossref","first-page":"6443","DOI":"10.1128\/JVI.00214-16","article-title":"Human cytomegalovirus induces an atypical activation of Akt to stimulate the survival of short-lived monocytes","volume":"90","author":"Cojohari","year":"2016","journal-title":"J. Virol"},{"key":"10.1074\/mcp.M116.065375_bib80","doi-asserted-by":"crossref","first-page":"3138","DOI":"10.1128\/JVI.02879-15","article-title":"Human cytomegalovirus stimulates the synthesis of select Akt-dependent antiapoptotic proteins during viral entry to promote survival of infected monocytes","volume":"90","author":"Peppenelli","year":"2016","journal-title":"J. Virol"},{"key":"10.1074\/mcp.M116.065375_bib81","doi-asserted-by":"crossref","first-page":"5886","DOI":"10.1128\/JVI.02656-05","article-title":"Cyclin-dependent kinase activity is required for efficient expression and posttranslational modification of human cytomegalovirus proteins and for production of extracellular particles","volume":"80","author":"Sanchez","year":"2006","journal-title":"J. Virol"},{"key":"10.1074\/mcp.M116.065375_bib82","doi-asserted-by":"crossref","first-page":"e1001096","DOI":"10.1371\/journal.ppat.1001096","article-title":"Cyclin-dependent kinase activity controls the onset of the HCMV lytic cycle","volume":"6","author":"Zydek","year":"2010","journal-title":"PLoS Pathog"},{"key":"10.1074\/mcp.M116.065375_bib83","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1038\/nrc2806","article-title":"Eph receptors and ephrins in cancer: bidirectional signalling and beyond","volume":"10","author":"Pasquale","year":"2010","journal-title":"Nat. Rev. Cancer"},{"key":"10.1074\/mcp.M116.065375_bib84","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1128\/JVI.00864-07","article-title":"Transcriptome analysis of NF-kappaB- and phosphatidylinositol 3-kinase-regulated genes in human cytomegalovirus-infected monocytes","volume":"82","author":"Chan","year":"2008","journal-title":"J. Virol"},{"key":"10.1074\/mcp.M116.065375_bib85","article-title":"TGF-beta induces M2-like macrophage polarization via SNAIL-mediated suppression of a pro-inflammatory phenotype","author":"Zhang","year":"2016","journal-title":"Oncotarget"},{"key":"10.1074\/mcp.M116.065375_bib86","doi-asserted-by":"crossref","first-page":"9810","DOI":"10.1073\/pnas.1606862113","article-title":"Mitotic MELK-eIF4B signaling controls protein synthesis and tumor cell survival","volume":"113","author":"Wang","year":"2016","journal-title":"Proc. Natl. Acad. Sci. U.S.A"},{"key":"10.1074\/mcp.M116.065375_bib87","doi-asserted-by":"crossref","first-page":"e0153518","DOI":"10.1371\/journal.pone.0153518","article-title":"OTSSP167 Abrogates mitotic checkpoint through inhibiting multiple mitotic kinases","volume":"11","author":"Ji","year":"2016","journal-title":"PLoS ONE"}],"container-title":["Molecular & Cellular Proteomics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S153594762033749X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S153594762033749X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1074\/mcp.M116.065375","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T00:54:18Z","timestamp":1761526458000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S153594762033749X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,4]]},"references-count":87,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2017,4]]}},"alternative-id":["S153594762033749X"],"URL":"https:\/\/doi.org\/10.1074\/mcp.m116.065375","relation":{},"ISSN":["1535-9476"],"issn-type":[{"value":"1535-9476","type":"print"}],"subject":[],"published":{"date-parts":[[2017,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Kinome Profiling Identifies Druggable Targets for Novel Human Cytomegalovirus (HCMV) Antivirals","name":"articletitle","label":"Article Title"},{"value":"Molecular & Cellular Proteomics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1074\/mcp.M116.065375","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 ASBMB. Currently published by Elsevier Inc; originally published by American Society for Biochemistry and Molecular Biology.","name":"copyright","label":"Copyright"}]}}